Daré (Dare) 2026 Earnings: A Comprehensive Investor Guide
As Daré gears up to discuss Q1 2026 results, investors will scrutinize cash runway, pipeline milestones, and strategi...
Innovative Skincare Clinical
Innovative Skincare Clinical presents study results and product evaluations to help you assess effectiveness and safety in modern skincare.
1,157 articlesMonashee Scales Back Structure: GPCR Bet Reassessed
A major hedge fund slashed its stake in Structure Therapeutics, prompting questions about the future path for GPCR-fo...
Crispr Therapeutics Editas Medicine: Better Buy in 2026?
Two top gene-editing names, two very different strategies. This guide breaks down CRISPR Therapeutics and Editas Medi...
Abridge Wants Operating System for Medicine Backed by NVIDIA
Abridge secures NVIDIA and Eli Lilly support to push an ambient AI platform toward a full hospital operating system. ...
Crispr Therapeutics Stock Been: A Roller-Coaster Year Unpacked
CRISPR Therapeutics stock has zigzagged all year, driven by pipeline milestones, regulatory updates, and funding need...
Moderna Recursion: Which Cutting-Edge Path Is Best in 2026
Two biotech powerhouses take very different routes: Moderna builds medicines with mRNA, while Recursion uses machine ...
MoonLake Immunotherapeutics' Sells Shares: Insider Moves Unpacked
When a company's chief financial officer sells a sizable stake, investors want to know what it means. This deep dive ...
Dyne Therapeutics 40% Rally Faces Fund Selloff Questions
A dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
Revolution Medicines Nearly 140% Rally — Is It Still a Buy?
Revolution Medicines has surged in 2026, with revolution medicines nearly 140% year-to-date gains drawing investor at...
Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Disc Medicine Lands Million: Investors React to FDA Catalyst
A private equity firm just disclosed a sizable stake in Disc Medicine, signaling growing confidence in its red blood ...
TransMedics Stock 104% Over: Is 2026 the Next Breakout?
TransMedics has surged 104% over the last year, catching investors’ eyes. This guide breaks down the business, the ca...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Crypto For Beginners
Best Dividend Etfs
Index
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Time To Notice Score Change After Secured Card
Secured Card Reported To Credit Bureaus Instantly
Secured Card Immediate Impact On Credit Score